Attributions of Change and Self-Efficacy in a Randomized Controlled Trial of Medication and Psychotherapy for Problem Drinking
Attributions of Change and Self-Efficacy in a Randomized Controlled Trial of Medication and Psychotherapy for Problem Drinking
复制标题
DOI：
10.1016/j.beth.2012.07.001
复制
发表时间：
2013-03-01
期刊：
影响因子：
3.7
通讯作者：
Muench, Frederick
中科院分区：
文献类型：
--
作者：
Schaumberg, Katherine;Kuerbis, Alexis;Muench, Frederick
目前的研究在一项双盲、随机对照试验中考察了参与者对改变的归因，该试验的对象是希望控制饮酒量的问题饮酒者。参与者被分配到12周的纳洛酮或安慰剂组，与动机访谈和认知行为治疗（MBSCT）沿着增强的药物管理干预或仅增强的药物管理相结合。治疗完成后，问卷调查评估了参与者对变化的归因沿着他们在维持治疗收益能力方面的自我效能。受试者的变化归因和自我效能的强度根据他们的治疗条件和他们的假设用药条件而不同。具体来说，那些在MBSCT条件下假设他们接受安慰剂的人与其他组相比，在没有药物治疗的情况下，对持续变化表现出更大的信心。如何治疗条件和归因的变化与自我效能的长期维护治疗收益进行了讨论。
The current study examines participants' attributions of change in a double-blind, randomized controlled trial of problem drinkers wanting to moderate their alcohol consumption. Participants were assigned to 12 weeks of naltrexone or placebo, which was paired with either combined motivational interviewing and cognitive behavioral therapy (MBSCT) along with an enhanced medication management intervention or enhanced medication management only. Upon treatment completion, a questionnaire assessed participants' attributions of change along with their self-efficacy in their ability to maintain treatment gains. Participants differed in strength of attributions of change and self-efficacy according to both their therapy condition and their hypothesized medication condition. Specifically, those in the MBSCT condition who hypothesized that they received placebo displayed greater confidence in continuing changes without medication compared with the other groups. How treatment condition and attributions of change relate to self-efficacy for long-term maintenance of treatment gains are discussed.